Comparative effectiveness research (CER) has the potential to improve health outcomes by helping people make better-informed decisions. But how do we know that CER will generate information that is useful? On September 30, in Washington, DC, you can be part of a conversation featuring a broad range of health care stakeholders—patients, providers, policymakers, payers, researchers, and those who fund research–by participating in an effort led by the National Health Council to create a framework to guide the development of CER, evaluate its results, and assist in communicating the findings to the right audiences. Register today and add your voice to this national effort to make CER useful.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
TagsSustainability BIOTECH public policy Biotechnology Industry USPTO BIO Events Intellectual Property patent biotechnology agriculture healthcare Benefits of biotech crops health biofuels Plant biotechnology biotech industry FDA Health Care Food climate change
- Most Popular
Latest VideoHans Schikan, CEO of Prosensa, on Rare Disease Drug Development View All >